SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Activity

10 hedge funds and large institutions have $118K invested in Sonnet BioTherapeutics in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, reducing their positions, and 2 closing their positions.

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SB
1
Suntrust Banks
Georgia
$27K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$49K
3
Jane Street
3
Jane Street
New York
$11K
4
QCIG
4
Quad-Cities Investment Group
Iowa
$4K
5
UBS Group
5
UBS Group
Switzerland
$1K

Top Sellers

1
Hudson Bay Capital Management
1
Hudson Bay Capital Management
Connecticut
$0
2
AFM
2
Anson Funds Management
Texas
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Renaissance Technologies
1
Renaissance Technologies
New York
$49K 67,307 +31,400 +87%
SB
2
Suntrust Banks
Georgia
$27K 36,765 +36,765 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$14K 19,975 – –
Jane Street
4
Jane Street
New York
$11K 15,763 +15,763 New
BlackRock
5
BlackRock
New York
$8K 10,692 – –
Bank of America
6
Bank of America
North Carolina
$4K 5,618 +335 +6%
QCIG
7
Quad-Cities Investment Group
Iowa
$4K 6,513 +4,386 +206%
UBS Group
8
UBS Group
Switzerland
$1K 1,203 +1,203 New
AFM
9
Anson Funds Management
Texas
– – -194,500 Closed
Hudson Bay Capital Management
10
Hudson Bay Capital Management
Connecticut
– – -17,052 Closed
CFA
11
Carroll Financial Associates
North Carolina
$0 261 – –
CFGS
12
Concourse Financial Group Securities
Alabama
– – – –
LWANC
13
Laurel Wealth Advisors (North Carolina)
North Carolina
$0 30 +30 New